1,639
Views
1
CrossRef citations to date
0
Altmetric
HPV – Research Article

Willingness to accept human papillomavirus vaccination in Jimma town, Ethiopia

ORCID Icon, &
Article: 2125701 | Received 29 Jul 2022, Accepted 13 Sep 2022, Published online: 26 Sep 2022

References

  • Mascaro V, Pileggi C, Currà A, Bianco A, Pavia M. HPV vaccination coverage and willingness to be vaccinated among 18–30 year-old students in Italy. Vaccine [Internet]. 2019;37(25):1–6. doi:10.1016/j.vaccine.2019.04.081.
  • Graham SV. Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol. 2010;5(10):1493–506. doi:10.2217/fmb.10.107.
  • Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107(6). doi:10.1093/jnci/djv086.
  • WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem and its associated goals and targets for the period 2020 – 2030. Vol. 2. US: United Nations General Assembly; 2020. p. 1–3.
  • Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman A, Unger ER, Williams, A, Iskander, J . CDC grand rounds: reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep [Internet]. 2014;63(4):69–72. http://www.ncbi.nlm.nih.gov/pubmed/24476977%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4584896.
  • Winer RL, Hughes JP, Feng Q, Xi LF, Lee SK, O’Reilly SF, Kiviat, NB, Koutsky, LA . Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women. Sex Transm Dis. 2012;39(11):848–56. doi:10.1097/OLQ.0b013e3182641f1c.
  • Reiter PL, Brewer NT, McRee AL, Gilbert P, Smith JS. Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sex Transm Dis. 2010;37(3):197–203. doi:10.1097/OLQ.0b013e3181bf542c.
  • Center H information. Human Papillomavirus and Related Diseases Report; 2019 Jun.
  • Depeursinge A, Racoceanu D, Iavindrasana J, Cohen G, Platon A, Poletti P-A, Müller, H . Fusing visual and clinical information for lung tissue classification in HRCT data. Artif Intell Med. 2010;229:ARTMED1118. doi:10.1016/j.123.
  • Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med (Baltim). 2007;45(2–3):107–14. doi:10.1016/j.ypmed.2007.05.013.
  • Commitments G, Ownership N. Federal democratic republic of Ethiopia the 2017 voluntary national reviews on SDGs of Ethiopia : government commitments. National Ownership and PerformanceTrends Content; 2017 Jun.
  • Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford, GM . Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121(3):621–32. doi:10.1002/ijc.22527.
  • Durusoy R, Yamazhan M, Taşbakan MI, Ergin I, Aysin M, Pullukçu H, Yamazhan, T . Research communication HPV vaccine awareness and willingness of first-year students entering university in Western Turkey. J Cancer Prev. 2010;11:1–7.
  • PATH CFVIAA. PATH’s center for vaccine innovation and access - path; 2020 Apr. http://sites.path.org/cvia/ .
  • Ndikom CM, Oboh PI. Perception, acceptance and uptake of human papillomavirus vaccine among female adolescents in selected secondary schools in Ibadan, Nigeria. Afr J Biomed Res. 2017;20:237–44.
  • Naing C, Pereira J, Abe T, Eh Zhen Wei D, Rahman Bajera IBA, Kavinda Perera UH. Predictors associated with the willingness to take human papilloma virus vaccination. J Community Health. 2012;10:288–93. doi:10.1007/s10900-011-9473-4.
  • Colón-López V, Del Toro-Mejías LM, Ortiz AP, Tortolero-Luna G, Palefsky JM. HPV awareness and willingness to HPV vaccination among high-risk men attending an STI clinic in Puerto Rico. P R Health Sci J. 2012;31:227–31.
  • Zhang X, Wang Z, Ren Z, Li Z, Ma W, Gao X. HPV vaccine acceptability and willingness-related factors among Chinese adolescents : a nation-wide study ABSTRACT. Hum Vaccin Immunother. 2020;00:1–8.
  • Yacouti A, Elkhoudri N, El got A, Benider A, Hadrya F, Baddou R, Forster, A, Mouallif, M . Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco. PLoS One [Internet]. 2022;17(4 April):1–10. doi:10.1371/journal.pone.0266081.
  • Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer. 2008;99(2):225–29. doi:10.1038/sj.bjc.6604454.
  • Gollu AN, Gore CK. Awareness and attitude of medical students regarding HPV infection and HPV vaccination. Asian Pacific J Cancer Care. 2021;6(1):41–46. doi:10.31557/apjcc.2021.6.1.41-46.
  • Yu C, Chen L, Ruan G, An J, Sun P. Evaluation of knowledge and attitude toward hpv and vaccination among medical staff, medical students, and community members in Fujian province. Risk Manag Healthc Policy. 2020;13:989–97. doi:10.2147/RMHP.S243048.
  • Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, Berenson A, Ramirez PT, Lu KH, Bodurka DC, et al. 2006. Are women ready for the HPV vaccine? ☆ Gynecol Oncol. 103:151–54. doi:10.1016/j.ygyno.2006.02.003.
  • De Groot AS, Tounkara K, Rochas M, Beseme S, Yekta S, Diallo FS, Tracy, JK, Teguete, I, Koita, OA . Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako. Mali PLoS One. 2017;12(2):1–13. doi:10.1371/journal.pone.0171631.
  • Turiho AK, Okello ES, Muhwezi WW, Katahoire AR. Perceptions of human papillomavirus vaccination of adolescent schoolgirls in western Uganda and their implications for acceptability of HPV vaccination: a qualitative study. BMC Res Notes. 2017;10(1):1–16. doi:10.1186/s13104-017-2749-8.
  • He J, He L. Knowledge of HPV and acceptability of HPV vaccine among women in western China: a cross-sectional survey. BMC Womens Health. 2018;18(1):1–8. doi:10.1186/s12905-018-0619-8.
  • Fernandes R, Potter BK, Little J. Attitudes of undergraduate university women towards HPV vaccination: a cross-sectional study in Ottawa, Canada. BMC Womens Health. 2018;18(1):1–9. doi:10.1186/s12905-018-0622-0.
  • Endarti D, Kristina SA, Farida MA, Rahmawanti Y, Andriani TK. Perception, and acceptance of HPV vaccination and screening for cervical cancer among women in Yogyakarta Province, Indonesia. J Cancer Prev. 2018;19:1105–11.
  • Grivna M, Schneider J, Nagelkerke NJ. Human papillomavirus vaccination uptake and factors related to uptake in a traditional desert city in the United Arab Emirates. Int J STD AIDS. 2011;6:400–04.
  • Santhanes D, Yong CP, Yap YY, Saw PS, Chaiyakunapruk N, Khan TM. Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions: a systematic review and meta-analysis. Sci Rep [Internet]. 2018;8(1):1–11. doi:10.1038/s41598-018-21912-x.
  • Chigozie N, Messiaa DKH, Adebola A. Men ’ s willingness to support HPV vaccination and cervical cancer screening in Nigeria. Health Promot Int. 2021;10:1–14.
  • Dereje N, Ashenafi A, Abera A, Melaku E, Yirgashewa K, Yitna M, Shewaye, S, Fasil, T, Yoseph, Y. Knowledge and acceptance of HPV vaccination and its associated factors among parents of daughters in Addis Ababa, Ethiopia: a community-based cross-sectional study. Infect Agent Cancer [Internet]. 2021;16(1):1–7. doi:10.1186/s13027-021-00399-8.
  • Sopian MM, Azdiana S, Din T, Hussin H. Obstacles to implementing the HPV vaccine. Asian Pacific J Cancer Care. 2019;4(4):165–69. doi:10.31557/apjcc.2019.4.4.165-169.
  • Minyihun A, Atnafu A, Mekonnen ZA, Minyihun A. Acceptance of human papillomavirus vaccination and associated factors among parents of daughters in Gondar Town, Northwest Ethiopia. Cancer Manage Res. 2020;12:8519–26. doi:10.2147/CMAR.S275038.